Based on the binding capacity and correlation analysis, bioinformatics also revealed that SMAD7 is among the top target of miR-92a, the blood and stool-based biomarker of CRC (Chen et al., 2018) (Table 1). This evidence concerns the gene SMAD7 and colorectal carcinoma.